Home  |   About  |   Theory  |   Tutorials  |   FAQ  |   Bahar Lab  |   Statistics


Network of interactions between drugs (red spheres) and targets (blue spheres) is displayed above.
The red lines are used for the predicted interactions and the thickness of edges indicate the confidence score of predictions.

Data source: DrugBank-all; Query type: target; # of requested predictions: 20; Secondary interactions: no
Input target 1: P08631
No. Gene UniProt ID Protein Name Pathway PDB
1 HCK P08631 Tyrosine-protein kinase HCK hsa04062; hsa04666; hsa05167

5 known interactions (drugs) of input target (HCK): Tyrosine-protein kinase HCK
No. Group Type Drug ID Drug Name SMILES
⇨ TargetHunter
1 Experimental SmallMoleculeDrug DB01962 Phosphonotyrosine Thumb
2 Experimental;
SmallMoleculeDrug DB04216 Quercetin Thumb
3 Approved;
SmallMoleculeDrug DB12010 Fostamatinib Thumb
4 Experimental SmallMoleculeDrug DB01809 1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine Thumb
5 Approved SmallMoleculeDrug DB06616 Bosutinib Thumb

20 predicted interactions (drugs) of input target (HCK): Tyrosine-protein kinase HCK
No. Group Type Drug ID Drug Name SMILES
⇨ TargetHunter
Image Confidence score
1 Approved;
SmallMoleculeDrug DB01254 Dasatinib Thumb 43.6%
2 Approved SmallMoleculeDrug DB08896 Regorafenib Thumb 38.2%
3 Approved;
SmallMoleculeDrug DB08901 Ponatinib Thumb 34.3%
4 Approved SmallMoleculeDrug DB05294 Vandetanib Thumb 27.1%
5 Approved SmallMoleculeDrug DB09079 Nintedanib Thumb 26.7%
6 Approved;
SmallMoleculeDrug DB00398 Sorafenib Thumb 26.1%
7 Experimental SmallMoleculeDrug DB08699 1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine Thumb 24.5%
8 Approved;
SmallMoleculeDrug DB04868 Nilotinib Thumb 24.1%
9 Investigational SmallMoleculeDrug DB12742 Amuvatinib Thumb 23.7%
10 Experimental SmallMoleculeDrug DB02010 Staurosporine Thumb 22.8%
11 Experimental SmallMoleculeDrug DB02375 Myricetin Thumb 21.3%
12 Approved SmallMoleculeDrug DB00619 Imatinib Thumb 20.4%
13 Experimental SmallMoleculeDrug DB03023 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine Thumb 19.3%
14 Approved SmallMoleculeDrug DB06589 Pazopanib Thumb 18.9%
15 Approved;
SmallMoleculeDrug DB08875 Cabozantinib Thumb 18.7%
16 Approved;
SmallMoleculeDrug DB08912 Dabrafenib Thumb 18.2%
17 Investigational SmallMoleculeDrug DB05146 XL820 Thumb 18.1%
18 Investigational SmallMoleculeDrug DB05184 XL228 Thumb 17.8%
19 Experimental SmallMoleculeDrug DB03628 ISO24 Thumb 17.7%
20 Investigational SmallMoleculeDrug DB06080 ABT-869 Thumb 17.7%


Reference:  Hongchun Li, Fen Pei, D. Lansing Taylor and Ivet Bahar. (2020) QuartataWeb: Integrated Chemical–Protein-Pathway Mapping for Polypharmacology and Chemogenomics. Bioinformatics 36(12), 3935–3937.


The QuartataWeb server is maintained by the Bahar Lab at the Department of Computational & Systems Biology at the University of Pittsburgh, School of Medicine, and sponsored by the NIH awards P41 GM103712 and P01 DK096990; and by the Li Lab at Research Center for Computer-Aided Drug Discovery at Shenzhen Institutes of Advanced Technology, CAS.

For questions and comments please contact Hongchun Li.